Holly Surrency
Primary Care · Aiken, SCNPI 1104261916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 432 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 15.4% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 432 payments — averaging $18.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$778
- GSK$711
- Lilly USA, LLC$567
- Novo Nordisk$510
- Bayer$403
- plus $4K from 33 others
What the payments were for
- Food & beverage$7,924100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,944 in reported general payments places this provider in the 90th percentile of 115 primary care providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $71,412 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 67 | $64,400 |
| FarxigaDapagliflozin Propanediol | 48 | $53,041 |
| MounjaroTirzepatide | 44 | $52,204 |
| JanuviaSitagliptin Phosphate | 47 | $43,702 |
| VraylarCariprazine Hcl | 26 | $39,055 |
| RybelsusSemaglutide | 20 | $38,419 |
| XareltoRivaroxaban | 39 | $37,023 |
| JardianceEmpagliflozin | 36 | $36,598 |
| MyrbetriqMirabegron | 42 | $29,880 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $27,364 |
| EliquisApixaban | 22 | $25,454 |
| Repatha SureclickEvolocumab | 33 | $22,314 |
| KerendiaFinerenone | 23 | $15,230 |
| VascepaIcosapent Ethyl | 22 | $12,040 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $510 | $109,83174 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $1,226 | $87,50596 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $711 | $74,60186 claims |
| MerckJanuvia, Janumet, Steglujan | $13 | $59,31670 claims |
| Lilly USA, LLCMounjaro | $567 | $52,20444 claims |
| AbbVieVraylar | $778 | $39,05526 claims |
| Johnson & JohnsonXarelto | $209 | $37,02339 claims |
| Boehringer IngelheimJardiance | $277 | $36,59836 claims |
| Astellas Pharma US IncMyrbetriq | $212 | $29,88042 claims |
| PfizerEliquis | $367 | $25,45422 claims |
| BayerKerendia | $403 | $15,23023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 115 primary care providers in South Carolina.
Other primary care in Aiken
- Destiny HowellAiken$1K
- Sarah TomashefskiGreenville$23K
- Samantha VaughtNorth Myrtle Beach$15K
- Cynthia SmithSeneca$10K
- William ByrdSumter$10K
- Kathleen BoonePawleys Island$9K
- Amanda GroomeGreenville$9K
- Jessica BoldenAnderson$8K
- Caren ArnetteDillon$7K
- Heather MartinSeneca$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.